Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07217990 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Name: Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer — clinical trial record (NCT07217990)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NoCUT-BC

StatusNot Yet Recruiting

PhasePhase 1/2

SponsorOhio State University Comprehensive Cancer Center

Started2026-09-15

View on ClinicalTrials.gov ↗

Amendment history

2026-06-20

Study Status v2

Start date2026-04-15→2026-09-15

2026-02-12

Study Status, IPDSharing v1

Start date2025-12-15→2026-04-15

2025-10-15

Original filing

Ohio State University Comprehensive Cancer Center

147 trials monitored

See 9 trials at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

Triple-Negative Breast Cancer

594 trials monitored

See 37 trials at risk

HER2-Positive Cancer

324 trials monitored

See 21 trials at risk

This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.

Trial Details

NCT Number	NCT07217990
Lead Sponsor	Ohio State University Comprehensive Cancer Center Collaborators: Gateway for Cancer Research
Conditions	Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer
Enrollment	84 participants
Start Date	2026-09-15
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-24